Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

ABBOTT LABORATORIES Director's Dealing 2008

Dec 23, 2008

29777_dirs_2008-12-23_20e95b36-25a1-47f4-8225-a3eb35568d83.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: ABBOTT LABORATORIES (ABT)
CIK: 0000001800
Period of Report: 2008-12-15

Reporting Person: Warmuth Michael J (Senior Vice President)

Holdings (Non-Derivative)

Security Shares Ownership
Common shares without par value 34979 Direct
Common shares without par value 23 Indirect
Common shares without par value 72 Indirect

Holdings (Derivative)

Security Exercise Price Expiration Underlying Shares Ownership
Option (right to buy) $52.54 2017-02-15 Common shares (8933) Direct
Option (right to buy) $55.56 2018-02-14 Common shares (8500) Direct
Option (right to buy) $55.56 2018-02-14 Common shares (8500) Direct
Option (right to buy) $55.56 2018-02-14 Common shares (8500) Direct
Option (right to buy) $54.03 2009-02-11 Common shares (4514) Direct
Option (right to buy) $54.03 2013-02-13 Common shares (4540) Direct
Option (right to buy) $57.93 2013-02-13 Common shares (2649) Direct

Footnotes

F1: Balance in the Abbott Laboratories Stock Retirement Trust as of December 19, 2008.

F2: The reporting person disclaims beneficial ownership of all securities held by his spouse.

F3: Employee stock options granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3.